| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824370 | Clinical Therapeutics | 2016 | 16 Pages |
Abstract
Targeting single molecular abnormalities or cancer pathways has achieved good clinical responses that have modestly affected survival in some cancers. However, this approach to cancer treatment is still reductionist, and many challenges need to be met to improve treatment outcomes with our patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jon MD, PhD, Cristiano MD, Santiago MD, Irene PhD, Sonia PhD, Luis MD, PhD,